Eric Lewis

1.9k total citations
28 papers, 702 citations indexed

About

Eric Lewis is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Eric Lewis has authored 28 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Hematology and 6 papers in Immunology. Recurrent topics in Eric Lewis's work include Multiple Myeloma Research and Treatments (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Statistical Methods in Clinical Trials (4 papers). Eric Lewis is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Statistical Methods in Clinical Trials (4 papers). Eric Lewis collaborates with scholars based in United States, United Kingdom and Canada. Eric Lewis's co-authors include David Rampe, Javier Grau, Michael Murawsky, Per Soelberg Sørensen, Susan VanMeter, Sarah Kavanagh, Aaron Miller, Jerry M. Tolson, Richard Grove and Daren Austin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Eric Lewis

26 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Lewis United States 14 265 172 134 125 124 28 702
Matthias Herrmann Germany 8 233 0.9× 36 0.2× 85 0.6× 124 1.0× 118 1.0× 29 747
Victor S. Sloan United States 14 227 0.9× 122 0.7× 105 0.8× 33 0.3× 503 4.1× 33 1.2k
Risto S Cvetkovi New Zealand 8 91 0.3× 130 0.8× 137 1.0× 85 0.7× 38 0.3× 9 506
Nader Tajik Iran 16 95 0.4× 74 0.4× 69 0.5× 62 0.5× 252 2.0× 43 696
Tamyra Downs United States 14 179 0.7× 64 0.4× 128 1.0× 53 0.4× 75 0.6× 19 830
A. L. Pasqui Italy 14 69 0.3× 151 0.9× 34 0.3× 47 0.4× 141 1.1× 30 595
William McCormack Ireland 11 238 0.9× 30 0.2× 136 1.0× 73 0.6× 453 3.7× 17 839
Alan M. Miller United States 15 98 0.4× 29 0.2× 155 1.2× 100 0.8× 109 0.9× 34 546
Qun Hu China 11 278 1.0× 21 0.1× 137 1.0× 43 0.3× 42 0.3× 78 628
Rachel Caron United States 6 144 0.5× 288 1.7× 174 1.3× 16 0.1× 323 2.6× 9 875

Countries citing papers authored by Eric Lewis

Since Specialization
Citations

This map shows the geographic impact of Eric Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Lewis more than expected).

Fields of papers citing papers by Eric Lewis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Lewis. The network helps show where Eric Lewis may publish in the future.

Co-authorship network of co-authors of Eric Lewis

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Lewis. A scholar is included among the top collaborators of Eric Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Lewis. Eric Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Shikako‐Thomas, Keiko, et al.. (2020). Adaptive Musical Instruments (AMIs): Past, Present, and Future Research Directions. Canadian Journal of Disability Studies. 9(1). 122–142. 2 indexed citations
4.
Ball, Greg, Tjark Reblin, J.R. Buchanan, et al.. (2019). A Framework for Safety Evaluation Throughout the Product Development Life-Cycle. Therapeutic Innovation & Regulatory Science. 54(4). 821–830. 8 indexed citations
5.
Bar‐Or, Amit, Richard Grove, Daren Austin, et al.. (2018). Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis. Neurology. 90(20). e1805–e1814. 154 indexed citations
6.
Duke, Susan P., et al.. (2017). Quantitative Methods for Safety Monitoring of Rare Serious Adverse Events. Pharmaceutical Medicine. 31(2). 113–118. 3 indexed citations
7.
Patton, W. N., Robert W. Lindeman, Andrew C. Butler, et al.. (2015). An open-label, single-arm, phase 1 study to assess biomarker effects, efficacy and safety of ofatumumab in patients with refractory chronic lymphocytic leukemia. Leukemia & lymphoma. 56(10). 2819–2825. 4 indexed citations
8.
Seino, Yutaka, Nobuya Inagaki, Mark Bush, et al.. (2014). A randomized dose-finding study demonstrating the efficacy and tolerability of albiglutide in Japanese patients with type 2 diabetes mellitus. Current Medical Research and Opinion. 30(6). 1095–1106. 27 indexed citations
9.
10.
Newby, L. Kristin, Ignacio Rodríguez, John K. Finkle, et al.. (2011). Troponin measurements during drug development—considerations for monitoring and management of potential cardiotoxicity. American Heart Journal. 162(1). 64–73. 28 indexed citations
11.
Rampe, David, Michael Murawsky, Javier Grau, & Eric Lewis. (1998). The Antipsychotic Agent Sertindole is a High Affinity Antagonist of the Human Cardiac Potassium Channel HERG. Journal of Pharmacology and Experimental Therapeutics. 286(2). 788–793. 142 indexed citations
12.
Lacerda, Antonio E., Mary Louise Roy, Eric Lewis, & David Rampe. (1997). Interactions of the Nonsedating Antihistamine Loratadine with a Kv1.5-Type Potassium Channel Cloned from Human Heart. Molecular Pharmacology. 52(2). 314–322. 39 indexed citations
13.
Yu, Dale K., Earl Nordbrock, Eric Lewis, et al.. (1995). Population pharmacokinetics of teicoplanin in patients with endocarditis. Journal of Pharmacokinetics and Biopharmaceutics. 23(1). 25–39. 15 indexed citations
14.
Losonsky, Genevieve A., et al.. (1994). Successful Treatment of Meningitis Due to Multiply Resistant Enterococcus faecium with a Combination of Intrathecal Teicoplanin and Intravenous Antimicrobial Agents. Clinical Infectious Diseases. 19(1). 163–165. 36 indexed citations
15.
Thompson, Gary A., Michael T. Kenny, Eric Lewis, et al.. (1992). Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30MGKG−1. Biopharmaceutics & Drug Disposition. 13(8). 571–581. 5 indexed citations
16.
Thompson, Gary A., et al.. (1992). Pharmacokinetics of teicoplanin upon multiple dose intravenous administration to normal healthy male volunteers. Biopharmaceutics & Drug Disposition. 13(3). 213–220. 19 indexed citations
17.
Thompson, Gary A., et al.. (1992). Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteers. Antimicrobial Agents and Chemotherapy. 36(1). 115–120. 22 indexed citations
18.
Lewis, Eric, et al.. (1991). Pharmacokinetics and Bioavailability of a New Formulation of Teicoplanin following Intravenous and Intramuscular Administration to Humans. Journal of Pharmaceutical Sciences. 80(6). 605–607. 23 indexed citations
19.
Nair, Madhavan, Eric Lewis, & Stanley A. Schwartz. (1986). Immunoregulatory dysfunctions in type I diabetes: Natural and antibody-dependent cellular cytotoxic activities. Journal of Clinical Immunology. 6(5). 363–372. 21 indexed citations
20.
Graesser, Arthur C., et al.. (1984). The Impact of Different Information Sources on Idea Generation. Written Communication. 1(3). 341–364. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthias Herrmann Breakdown of academic impact, for papers by Victor S. Sloan Breakdown of academic impact, for papers by Risto S Cvetkovi Breakdown of academic impact, for papers by Nader Tajik Breakdown of academic impact, for papers by Tamyra Downs Breakdown of academic impact, for papers by A. L. Pasqui Breakdown of academic impact, for papers by William McCormack Breakdown of academic impact, for papers by Alan M. Miller Breakdown of academic impact, for papers by Qun Hu Breakdown of academic impact, for papers by Rachel Caron
Rankless by CCL
2026